HomeNLSP • NASDAQ
add
NLS Pharmaceutics AG
Previous close
$4.22
Day range
$4.32 - $4.55
Year range
$4.08 - $40.60
Market cap
5.09M USD
Avg Volume
23.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.13M | -37.34% |
Net income | -2.28M | 41.96% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.13M | 37.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 897.68K | -89.97% |
Total assets | 1.85M | -80.09% |
Total liabilities | 10.68M | 78.13% |
Total equity | -8.83M | — |
Shares outstanding | 1.00M | — |
Price to book | -0.39 | — |
Return on assets | -288.20% | — |
Return on capital | 73.92% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.28M | 41.96% |
Cash from operations | -1.19M | 61.57% |
Cash from investing | — | — |
Cash from financing | 816.87K | -88.17% |
Net change in cash | -376.89K | -109.93% |
Free cash flow | -1.32M | 37.23% |
About
Founded
2015
Website
Employees
3